552
Views
41
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial

, , , &
Pages 478-484 | Received 19 Apr 2015, Accepted 10 May 2015, Published online: 10 Jul 2015

References

  • McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. Br Med J. 2008;336:658–62.
  • Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature Reviews Neurology. 2011;7:616–30.
  • Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059–63.
  • Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010;11:542–8.
  • Couratier P, Desport JC, Antonini MT, Mabrouk T, Perna A, Vincent F, et al. Review of nutritional and respiratory support in ALS. Revue Neurologique. 2004;160: 243–50.
  • Desport J-C, Torny F, Lacoste M, Preux P-M, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegenerative Diseases. 2005; 2:202–7.
  • Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurology. 2011;10:75–82.
  • Zinman L, Sadeghi R, Gawel M, Patton D, Kiss A. Are statin medications safe in patients with ALS? Amyotroph Lateral Scler. 2008;9:223–8.
  • Lenglet T, Lacomblez L, Abitbol JL, Ludolph A, Mora JS, Robberecht W, et al. A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis. European Journal of Neurology. 2014;21:529–36.
  • StataCorp. (2011) Stata Statistical Software: Release 12. College Station, TX: StataCorp LP
  • Morris JA, Gardner MJ. Statistics in Medicine: calculating confidence intervals for relative risks (odds ratios) and standardized ratios and rates.British Medical Journal (Clinical research ed.)296.6632 (1988): 1313.
  • Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidaemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004–9.
  • Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. Journal of Neurology. 2011;258:613–7.
  • Chio A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2010;73:1681–5.
  • Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. 2011; 82:638–42.
  • Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills A-M. Body mass index, not dyslipidaemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle and Nerve. 2011;44:20–4.
  • Wietlisbach V, Marques-Vidal P, Kuulasmaa K, Karvanen J, Paccaud F. The relation of body mass index and abdominal adiposity with dyslipidaemia in 27 general populations of the WHO MONICA Project. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2013;23: 432–42.
  • Gostynski M, Gutzwiller F, Kuulasmaa K, Dörling A, Ferrario M, Grafnetter D, et al. Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project. International Journal of Obesity and Related Metabolic Disorders. 2004;28:1082–90.
  • Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar J-L, Loeffler J-P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:11159–64.
  • Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled phase II trial. Lancet. 2014;383: 2065–72.
  • Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Internal Medicine (Tokyo, Japan) 2012;51:1501–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.